Cutaneous anthrax treating drug

A technology of drugs and raw materials, applied in the field of traditional Chinese medicine preparations, can solve the problems of increasing toxic and side effects, difficulty of treatment, and germ generation, and achieve safe, non-toxic and side effects, good effect and definite curative effect

Inactive Publication Date: 2015-05-27
王芳
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the abuse of antibiotics in recent years, the bacteria have developed drug r

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] 1. Formula and weight ratio: 18 parts of Scutellaria baicalensis, 10 parts of Coptis chinensis, 20 parts of honeysuckle, 30 parts of wild chrysanthemum, 50 parts of dandelion, 25 parts of Viola chinensis, 12 parts of geranium, 0.1 part of toadstool, 15 parts of Angelica dahurica, honeysuckle 25 parts, 16 parts forsythia.

[0019] 2. Production method: The above-mentioned raw materials are weighed and prepared according to the proportion, processed with pharmaceutical equipment to pass, purified and concentrated, and made into different dosage forms such as capsules, tablets, pills, granules, and oral liquids for future use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a cutaneous anthrax treating drug, and belongs to the technical field of traditional Chinese medicine preparations, wherein the cutaneous anthrax treating drug mainly comprises 11 bulk drugs such as scutellaria baicalensis, coptis chinensis, honeysuckle, viola philippica, radix semiaquilegiae, cinobufagin venom toad, angelica dahurica and the like, and the bulk drugs are prepared into different dosage forms such as capsules, tablets, oral liquid and the like for spare by using drug preparation equipment. The cutaneous anthrax treating drug of the present invention has functions of heat clearing, detoxification, blood circulation activating, slough removing, muscle growing and purulent discharge, and has characteristics of good treatment effect, safety, and no toxic-side effect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations. Background technique [0002] Epidemic furuncle, modern medicine is called cutaneous anthrax. At the beginning, there is a small erythematous papule on the skin, itchy but not painful, shaped like mosquito-flea spots, and the whole body may have a slight fever. Blisters occur on local erythema in the middle stage, but dry quickly, forming dark red or black flesh. Then the swelling became loose and intensified, soft and rootless, and groups of gray-green blisters formed around the carrion, much like cowpox. Then the blister line is black and sunken, shaped like an umbilicus, and the fever also increases at this time. In the later stage, if the central carrion begins to separate from the normal skin, or a small amount of pus flows out, the surrounding swelling becomes more and more limited, and the body heat gradually subsides, but the sores heal slowly. Modern...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/86A61P31/04A61P17/00A61K35/65
Inventor 王芳陈洪涛陈冠卿
Owner 王芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products